Literature DB >> 19663403

Synthesis of a highly water-soluble derivative of amphotericin B with attenuated proinflammatory activity.

Samusi A Adediran1, Timothy P Day, Diptesh Sil, Matthew R Kimbrell, Hemamali J Warshakoon, Subbalakshmi S Malladi, Sunil A David.   

Abstract

Amphotericin B (AmB), a well-known polyene antifungal agent, displays a marked tendency to self-associate and, as a consequence, exhibits very poor solubility in water. The therapeutic index of AmB is low and is associated with significant dose-related nephrotoxicity, as well as acute, infusion-related febrile reactions. Reports in the literature indicate that the toxicity of AmB may be related to the physical state of the drug. Reaction of AmB in dimethylformamide with bis(dimethylaminopropyl)carbodiimide yielded an unexpected N-alkylguanidine/N-acylurea bis-adduct of AmB which was highly water-soluble. The absorption spectrum of the AmB derivative in water indicated excellent monomerization, and the antifungal activities of reference AmB and its water-soluble derivative against Candida albicans were found to be virtually identical. Furthermore, the water-soluble adduct is significantly less active in engaging TLR4, which would suggest that the adduct may be less proinflammatory.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19663403      PMCID: PMC3709255          DOI: 10.1021/mp9001602

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  52 in total

Review 1.  Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF).

Authors:  S Akira; T Hirano; T Taga; T Kishimoto
Journal:  FASEB J       Date:  1990-08       Impact factor: 5.191

Review 2.  Amphotericin B-induced nephrotoxicity: a review.

Authors:  V Fanos; L Cataldi
Journal:  J Chemother       Date:  2000-12       Impact factor: 1.714

3.  Secretion of proinflammatory cytokines and chemokines during amphotericin B exposure is mediated by coactivation of toll-like receptors 1 and 2.

Authors:  Raymund R Razonable; Martin Henault; Linda N Lee; Carmen Laethem; Paul A Johnston; Harold L Watson; Carlos V Paya
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

4.  Lipopolysaccharide sequestrants: structural correlates of activity and toxicity in novel acylhomospermines.

Authors:  Kelly A Miller; E V K Suresh Kumar; Stewart J Wood; Jens R Cromer; Apurba Datta; Sunil A David
Journal:  J Med Chem       Date:  2005-04-07       Impact factor: 7.446

5.  Pharmacokinetics, excretion, and mass balance of liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate in humans.

Authors:  Ihor Bekersky; Robert M Fielding; Dawna E Dressler; Jean W Lee; Donald N Buell; Thomas J Walsh
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

6.  Liposomal amphotericin B activates antifungal resistance with reduced toxicity by diverting Toll-like receptor signalling from TLR-2 to TLR-4.

Authors:  Silvia Bellocchio; Roberta Gaziano; Silvia Bozza; Giordano Rossi; Claudia Montagnoli; Katia Perruccio; Mario Calvitti; Lucia Pitzurra; Luigina Romani
Journal:  J Antimicrob Chemother       Date:  2005-01-13       Impact factor: 5.790

Review 7.  In search of the holy grail of antifungal therapy.

Authors:  Stanley W Chapman; Donna C Sullivan; John D Cleary
Journal:  Trans Am Clin Climatol Assoc       Date:  2008

Review 8.  The reformulation of amphotericin B for oral administration to treat systemic fungal infections and visceral leishmaniasis.

Authors:  Sheila J Thornton; Kishor M Wasan
Journal:  Expert Opin Drug Deliv       Date:  2009-03       Impact factor: 6.648

9.  Comparison of the immunostimulatory and proinflammatory activities of candidate Gram-positive endotoxins, lipoteichoic acid, peptidoglycan, and lipopeptides, in murine and human cells.

Authors:  Matthew R Kimbrell; Hemamali Warshakoon; Jens R Cromer; Subbalakshmi Malladi; Jennifer D Hood; Rajalakshmi Balakrishna; Tandace A Scholdberg; Sunil A David
Journal:  Immunol Lett       Date:  2008-04-18       Impact factor: 3.685

10.  Effects of aggregation and solvent on the toxicity of amphotericin B to human erythrocytes.

Authors:  P Legrand; E A Romero; B E Cohen; J Bolard
Journal:  Antimicrob Agents Chemother       Date:  1992-11       Impact factor: 5.191

View more
  5 in total

1.  Structure-activity relationships in human toll-like receptor 7-active imidazoquinoline analogues.

Authors:  Nikunj M Shukla; Subbalakshmi S Malladi; Cole A Mutz; Rajalakshmi Balakrishna; Sunil A David
Journal:  J Med Chem       Date:  2010-06-10       Impact factor: 7.446

Review 2.  A brief history of antibiotics and select advances in their synthesis.

Authors:  Kyriacos C Nicolaou; Stephan Rigol
Journal:  J Antibiot (Tokyo)       Date:  2017-07-05       Impact factor: 2.649

3.  Imbuing aqueous solubility to amphotericin B and nystatin with a vitamin.

Authors:  Timothy P Day; Diptesh Sil; Nikunj M Shukla; Asokan Anbanandam; Victor W Day; Sunil A David
Journal:  Mol Pharm       Date:  2010-12-17       Impact factor: 4.939

4.  Identification of Adjuvantic Activity of Amphotericin B in a Novel, Multiplexed, Poly-TLR/NLR High-Throughput Screen.

Authors:  Alex C D Salyer; Giuseppe Caruso; Karishma K Khetani; Lauren M Fox; Subbalakshmi S Malladi; Sunil A David
Journal:  PLoS One       Date:  2016-02-26       Impact factor: 3.240

5.  Pore-forming activity of new conjugate antibiotics based on amphotericin B.

Authors:  Svetlana S Efimova; Anna N Tevyashova; Evgenia N Olsufyeva; Evgeny E Bykov; Olga S Ostroumova
Journal:  PLoS One       Date:  2017-11-29       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.